Advanced hybrid nanomaterials for biomedical applications

W Park, H Shin, B Choi, WK Rhim, K Na… - Progress in Materials …, 2020 - Elsevier
As the field of biomedical engineering has become more precise and sophisticated, the
demand for highly-functionalized biomaterials has risen. In particular, novel …

Coronary balloon angioplasty, stents, and scaffolds

RA Byrne, GW Stone, J Ormiston, A Kastrati - The Lancet, 2017 - thelancet.com
Since the first coronary angioplasty on Sept 16, 1977, the field of percutaneous coronary
intervention has evolved rapidly. Now marking its 40th anniversary, percutaneous coronary …

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy …

M Valgimigli, H Bueno, RA Byrne, JP Collet… - European heart …, 2018 - academic.oup.com
Guidelines, Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dual antiplatelet therapy, Acute
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …

[PDF][PDF] European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection

D Adlam, F Alfonso, A Maas, C Vrints - European Heart Journal, 2018 - academic.oup.com
Spontaneous coronary artery dissection (SCAD) has long been recognized as a cause of
acute coronary syndromes (ACS). Initially considered very rare and associated primarily with …

Bioresorbable scaffolds versus metallic stents in routine PCI

JJ Wykrzykowska, RP Kraak, SH Hofma… - … England Journal of …, 2017 - Mass Medical Soc
Background Bioresorbable vascular scaffolds were developed to overcome the
shortcomings of drug-eluting stents in percutaneous coronary intervention (PCI). We …

3-year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III trial

DJ Kereiakes, SG Ellis, C Metzger, RP Caputo… - Journal of the American …, 2017 - jacc.org
Abstract Background: The Absorb everolimus-eluting poly-L-lactic acid–based
bioresorbable vascular scaffold (BVS) provides early drug delivery and mechanical support …

Fully bioresorbable vascular scaffolds: lessons learned and future directions

H Jinnouchi, S Torii, A Sakamoto… - Nature Reviews …, 2019 - nature.com
Fully bioresorbable scaffolds (BRS) were designed to overcome the limitations of metallic
drug-eluting stents, which permanently cage the vessel wall, thereby preventing normal …

Predictors of stent thrombosis and their implications for clinical practice

T Gori, A Polimeni, C Indolfi, L Räber… - Nature Reviews …, 2019 - nature.com
Stent thrombosis (ST) is a rare but severe complication of coronary procedures with high
mortality, high relapse rate and a very complex pathophysiology. An individual's …

2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials …

ZA Ali, PW Serruys, T Kimura, R Gao, SG Ellis… - The Lancet, 2017 - thelancet.com
Background Bioresorbable vascular scaffolds (BVS) offer the potential to improve long-term
outcomes of percutaneous coronary intervention after their complete bioresorption …

Polymeric materials, advances and applications in tissue engineering: a review

MC Socci, G Rodríguez, E Oliva, S Fushimi… - Bioengineering, 2023 - mdpi.com
Tissue Engineering (TE) is an interdisciplinary field that encompasses materials science in
combination with biological and engineering sciences. In recent years, an increase in the …